Cold atmospheric plasma inhibits the growth of osteosarcoma cells by inducing apoptosis, independent of the device used.
apoptosis
cold atmospheric plasma
osteosarcoma
Journal
Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
04
04
2019
accepted:
11
10
2019
entrez:
4
1
2020
pubmed:
4
1
2020
medline:
4
1
2020
Statut:
ppublish
Résumé
Osteosarcoma (OS) is the most common tumor of the musculoskeletal system. Recently, cold atmospheric plasma (CAP) has been regarded as a promising anti-oncogenic therapy. Previous experimental studies have demonstrated that CAP treatment results in significant growth inhibition of human sarcoma and is able to induce apoptosis. However, due to device-specific parameters, there is a large variability in the antitumor effects of different CAP sources. In the present study, the cellular effects of CAP treatment from two different CAP devices were investigated and their pro-apoptotic efficacy was characterized. The OS cell lines, U2-OS and MNNG/HOS, were treated with two CAP devices, kINPen MED and MiniJet-R. Control groups were treated with argon. The anti-proliferative effect of each treatment was demonstrated using cell counting and the activation of apoptotic mechanisms was determined using Comet, TUNEL and Caspase-3/Caspase-7 assays. The results revealed that treatment of both OS cell lines with the two CAP sources resulted in significant inhibition of cell growth. Subsequently, the activation of Caspases and the induction of apoptotic DNA fragmentation was demonstrated. The biological effects of each CAP source did not differ significantly. The treatment of OS cells with CAP lead to an induction of apoptosis and a reduction of cell growth. Therefore, the biological effects of CAP appear to be general as the two devices of different design produced highly comparable cell responses. Therefore, the type of device used does not seem to affect the efficacy of CAP-based antitumor therapy.
Identifiants
pubmed: 31897140
doi: 10.3892/ol.2019.11115
pii: OL-0-0-11115
pmc: PMC6924118
doi:
Types de publication
Journal Article
Langues
eng
Pagination
283-290Informations de copyright
Copyright: © Haralambiev et al.
Références
Cell Death Dis. 2014 Feb 13;5:e1056
pubmed: 24525732
Br J Cancer. 2015 Jan 20;112(2):278-82
pubmed: 25422914
Cell Biochem Biophys. 2015 Mar;71(2):1097-104
pubmed: 25417058
Curr Protoc Immunol. 2015 Nov 02;111:A3.B.1-A3.B.3
pubmed: 26529666
Anticancer Res. 2017 Oct;37(10):5407-5414
pubmed: 28982850
Sci Rep. 2014 Nov 20;4:7129
pubmed: 25410636
Surg Oncol. 2015 Mar;24(1):9-15
pubmed: 25453577
PLoS One. 2015 Jun 17;10(6):e0126313
pubmed: 26083405
Oncologist. 2004;9(4):422-41
pubmed: 15266096
Int J Cancer. 2012 May 1;130(9):2185-94
pubmed: 21702038
J Chemother. 2010 Apr;22(2):119-24
pubmed: 20435572
Tumour Biol. 2013 Dec;34(6):3817-21
pubmed: 24014053
GMS Hyg Infect Control. 2017 Aug 08;12:Doc10
pubmed: 28840090
Anticancer Res. 2016 Nov;36(11):5915-5922
pubmed: 27793916
Int J Mol Sci. 2015 Jan 29;16(2):2971-3016
pubmed: 25642755
Biomed Res Int. 2015;2015:506059
pubmed: 26539504
Anticancer Res. 2017 Mar;37(3):1031-1038
pubmed: 28314261
Anticancer Res. 2019 Jan;39(1):151-157
pubmed: 30591452
Anticancer Res. 2017 Dec;37(12):6739-6744
pubmed: 29187451
Asia Pac J Clin Oncol. 2017 Apr;13(2):e104-e110
pubmed: 25870979
J Cell Biochem. 2015 Aug;116(8):1719-29
pubmed: 25736420
Oxid Med Cell Longev. 2019 Sep 3;2019:3873928
pubmed: 31565150
Int J Oncol. 2015 Nov;47(5):1655-62
pubmed: 26351772
Int Wound J. 2019 Feb;16(1):103-111
pubmed: 30311743
PLoS One. 2016 Sep 01;11(9):e0160667
pubmed: 27584003
Mol Biol Cell. 2014 May;25(9):1523-31
pubmed: 24574456
J Orthop Surg (Hong Kong). 2008 Aug;16(2):182-5
pubmed: 18725669
Sci Rep. 2016 Jul 01;6:29020
pubmed: 27364630
PLoS One. 2015 Jul 01;10(7):e0130350
pubmed: 26132846
Int J Mol Sci. 2017 Sep 19;18(9):null
pubmed: 28925941
Oxid Med Cell Longev. 2019 Sep 19;2019:8535163
pubmed: 31641425
In Vivo. 2015 Sep-Oct;29(5):611-6
pubmed: 26359422
J Med Virol. 2017 Jun;89(6):952-959
pubmed: 27696466
Bone Joint J. 2014 Oct;96-B(10):1396-403
pubmed: 25274928
PLoS One. 2014 Apr 23;9(4):e91947
pubmed: 24759730
Cancer Treat Rev. 2014 May;40(4):523-32
pubmed: 24345772
Clin Orthop Relat Res. 2008 Sep;466(9):2114-30
pubmed: 18563507
Br J Cancer. 2015 Apr 28;112(9):1536-45
pubmed: 25839988
PLoS One. 2017 Jan 19;12(1):e0169457
pubmed: 28103270
Sarcoma. 2011;2011:548151
pubmed: 21437228